Updated: Jul 6, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Scott Mintzer1, Michael R Sperling
1Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. scott.mintzer@jefferson.edu
Anteromesial temporal lobectomy (AMTL) effectively treats refractory temporal lobe epilepsy (TLE). However, sparing mesial structures may benefit select patients, particularly those without hippocampal sclerosis (HS), to reduce memory decline risks.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: